The 8th Biopharmaceutical Process Development Summit (2025BPD) is set to take place in Shanghai from August 7–8. This year’s conference will spotlight key areas across the biopharma landscape, including antibodies, XDCs, cell and gene therapies, nucleic acids, polypeptides, and small molecules. Special segments such as executive networking events, brainstorming sessions, and youth exchange forums will add depth to the conference. With over 5,000 industry professionals, 150+ expert speakers, and more than 100 high-quality exhibitors expected, the event aims to deliver cutting-edge insights, targeted networking opportunities, and access to trusted suppliers.

With midsummer in full bloom
Morimatsu welcomes you to join the show

Exhibit Preview

Morimatsu is deeply rooted in the field of biotechnology, keeping pace with the wave of innovation and continuously exploring cutting-edge areas such as vaccines, antibodies, and nucleic acids. We understand the challenges you face at every stage from R&D and process optimization to commercial production. Driven by a spirit of innovation and adaptability, we’re dedicated to helping you overcome obstacles and bring your products to market with confidence and stability.

At this year’s conference, Morimatsu will focus on key biopharmaceutical tracks, showcasing our latest breakthroughs in life sciences. Through three featured solutions, we’ll share cutting-edge technologies and explore emerging trends shaping the future of the industry.

1.Upstream Culture Solutions
2.Single-Use Solutions
3.Modular Plant Solutions

We warmly invite you to visit the Morimatsu booth. Let’s connect in person to explore the endless possibilities of bioprocess innovation and dive deep into the challenges and opportunities of industrialization. Together, let’s move forward and shape a new blueprint for the future of industrial transformation.

About Morimatsu LifeSciences

Morimatsu LifeSciences is a key business segment of Morimatsu International Holdings Limited (Stock Code: 2155.HK). It comprises Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Shanghai Mori-Biounion Technology Co., Ltd., Shanghai Morisora Technology Co., Ltd., Pharmadule Morimatsu AB, and its affiliated companies.

Morimatsu LifeSciences is dedicated in providing core equipment, process systems, and smart modular facility solutions, and services for the pharmaceutical, biopharmaceutical, medical aesthetics, and fast-moving consumer goods (FMCG) sectors including (cosmetics, food, and health supplements), as well as data centers.

Our team comprises highly experienced professionals with deep expertise in process R&D, engineering design, advanced manufacturing, compliance and validation consulting, production execution, and intelligent operations. With broad experience across diverse industries, we fully understand the unique characteristics and process requirements of various products. This enables us to deliver tailored, end-to-end process solutions from the conceptual design stage, precisely aligned with client’s specific needs.

Morimatsu LifeSciences has established a strong global presence, supported by advanced R&D centers, design hubs, and state-of-the-art manufacturing facilities worldwide. Our well-established service network spans Europe,USA,Asia-Pacific, and emerging markets. We have successfully delivered outstanding, customized solutions to clients in over 40 countries and regions, gaining extensive experience in international project execution.

As a multinational enterprise with core strengths in process technology, modular facility construction, and intelligent manufacturing, Morimatsu LifeSciences is dedicated to meeting the evolving equipment and system needs of our key industries. Through continuous innovation and technological advancement, we are steadily expanding our global footprint, driving our international strategy forward, and delivering Morimatsu’s expertise, reliability, and innovation to the global life sciences and related sectors.